Alder Biopharmaceuticals (ALDR) Reaches $9.40 After 5.00% Down Move; 7 Analysts Bullish LeMaitre Vascular (LMAT)

August 10, 2017 - By Marguerite Chambers

The stock of Alder Biopharmaceuticals Inc (NASDAQ:ALDR) is a huge mover today! About 157,327 shares traded. Alder Biopharmaceuticals Inc (NASDAQ:ALDR) has declined 33.67% since August 10, 2016 and is downtrending. It has underperformed by 50.37% the S&P500.The move comes after 8 months negative chart setup for the $636.51M company. It was reported on Aug, 10 by Barchart.com. We have $8.93 PT which if reached, will make NASDAQ:ALDR worth $31.83M less.

Among 11 analysts covering LeMaitre Vascular (NASDAQ:LMAT), 7 have Buy rating, 0 Sell and 4 Hold. Therefore 64% are positive. LeMaitre Vascular had 29 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Buy” rating by Benchmark on Wednesday, July 29. The rating was downgraded by Benchmark on Monday, July 10 to “Hold”. The firm earned “Buy” rating on Tuesday, May 3 by Roth Capital. As per Wednesday, February 22, the company rating was downgraded by Barrington Research. On Friday, December 4 the stock rating was maintained by Stifel Nicolaus with “Buy”. The firm has “Hold” rating given on Thursday, July 27 by Canaccord Genuity. The company was maintained on Wednesday, July 29 by TH Capital. As per Monday, December 7, the company rating was maintained by Dougherty & Company. As per Thursday, April 21, the company rating was maintained by Cowen & Co. The rating was downgraded by Sidoti on Thursday, September 22 to “Neutral”. See LeMaitre Vascular Inc (NASDAQ:LMAT) latest ratings:

28/07/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $32.0000 Maintain
27/07/2017 Broker: Canaccord Genuity Rating: Hold New Target: $30.0000 Maintain
28/07/2017 Broker: Roth Capital Rating: Buy New Target: $33.0000 Maintain
10/07/2017 Broker: Canaccord Genuity Old Rating: Buy New Rating: Hold Downgrade
10/07/2017 Broker: Benchmark Old Rating: Buy New Rating: Hold Downgrade
21/03/2017 Broker: First Analysis Rating: Overweight New Target: $29.00 Initiates Coverage On
22/02/2017 Broker: Barrington Research Old Rating: Outperform New Rating: Mkt Perform Downgrade

Since February 27, 2017, it had 0 buys, and 9 insider sales for $8.92 million activity. Kamke Trent G had sold 15,780 shares worth $477,822 on Wednesday, May 24. LeMaitre George W sold $2.83M worth of stock. 5,900 shares were sold by Roberts David B, worth $132,380 on Friday, March 10. The insider Wijas Michael T sold 2,346 shares worth $73,717.

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The company has market cap of $618.44 million. The Firm develops, makes and markets medical devices and implants used primarily in the field of vascular surgery. It has a 46.77 P/E ratio. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

About 17,481 shares traded. LeMaitre Vascular Inc (NASDAQ:LMAT) has risen 101.07% since August 10, 2016 and is uptrending. It has outperformed by 84.37% the S&P500.

Investors sentiment decreased to 1.12 in 2016 Q4. Its down 0.44, from 1.56 in 2016Q3. It worsened, as 11 investors sold LeMaitre Vascular Inc shares while 39 reduced holdings. 18 funds opened positions while 38 raised stakes. 10.81 million shares or 0.20% more from 10.78 million shares in 2016Q3 were reported. Renaissance Technology Lc owns 119,100 shares or 0% of their US portfolio. Grandeur Peak Global Ltd Liability reported 0.72% stake. Susquehanna Grp Inc Limited Liability Partnership has invested 0% in LeMaitre Vascular Inc (NASDAQ:LMAT). Ohio-based Strs Ohio has invested 0% in LeMaitre Vascular Inc (NASDAQ:LMAT). Driehaus Management Limited Company has 0.47% invested in LeMaitre Vascular Inc (NASDAQ:LMAT) for 519,042 shares. Goldman Sachs Grp Inc holds 13,667 shares. Millennium Lc invested in 107,132 shares or 0.01% of the stock. Rice Hall James Assoc Ltd Com holds 0.2% of its portfolio in LeMaitre Vascular Inc (NASDAQ:LMAT) for 156,264 shares. The Japan-based Blackrock Japan Ltd has invested 0% in LeMaitre Vascular Inc (NASDAQ:LMAT). Geode Limited Liability Corporation reported 0% in LeMaitre Vascular Inc (NASDAQ:LMAT). 6,307 are owned by Qs Investors Ltd Liability. Acadian Asset Mngmt Ltd Llc holds 0.01% of its portfolio in LeMaitre Vascular Inc (NASDAQ:LMAT) for 70,595 shares. 3,584 were reported by Legal General Group Public Ltd Co. Tfs Capital Lc holds 0.36% in LeMaitre Vascular Inc (NASDAQ:LMAT) or 53,568 shares. Jpmorgan Chase & holds 0% or 70,941 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com